Nov 19 (Reuters) - Cereno Scientific AB  CRNOSb.TE :
    * CERENO SCIENTIFIC IS ANNOUNCING THAT THE AUTHORITIES IN
BULGARIA
HAVE ISSUED APPROVAL OF START OF PHASE II CLINICAL TRIAL
    * COMPANY INTENDS TO START STUDY AT MID-YEAR 2020 WITH
INTENTION
OF DEMONSTRATING CS1'S PREVENTATIVE EFFECT AGAINST FORMATION OF
BLOOD CLOTS AFTER ORTHOPEDIC SURGERY
    * STUDY WILL BE CONDUCTED IN BOTH BULGARIA AND RUSSIA, AND
COMPANY
HAS PREVIOUSLY BEEN GRANTED TO START STUDY IN RUSSIA

Source text for Eikon:  ID:nWkr7ksw7p 
Further company coverage:  CRNOSb.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))